Cargando…
miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
BACKGROUND: Drug resistance is a major obstacle to successful chemotherapy for epithelial ovarian cancer (EOC). We found a subset of miRNAs associated with the response to first-line platinum-based chemotherapy in EOC by microarray, and miR-206 was one of the most significant miRNAs. The purposes of...
Autores principales: | Yu, Xiaotang, Zhang, Xinchen, Wang, Guang, Wang, Bo, Ding, Yanfang, Zhao, Jinyao, Liu, Hanlin, Cui, Shiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641844/ https://www.ncbi.nlm.nih.gov/pubmed/33292230 http://dx.doi.org/10.1186/s12935-020-01623-y |
Ejemplares similares
-
Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma
por: ZHANG, XINCHEN, et al.
Publicado: (2015) -
MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
por: Chen, Ai-Hua, et al.
Publicado: (2017) -
MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2
por: Zhao, Henan, et al.
Publicado: (2016) -
MiR-596 activated by EP300 controls the tumorigenesis in epithelial ovarian cancer by declining BRD4 and KPNA4
por: Wang, Deying, et al.
Publicado: (2020) -
Knockdown of lncRNA NEAT1 suppresses hypoxia-induced migration, invasion and glycolysis in anaplastic thyroid carcinoma cells through regulation of miR-206 and miR-599
por: Tan, Xiangrong, et al.
Publicado: (2020)